{"status":"success","data":{"title":"Clostridium Difficile Infection","slug":"cdiff","tags":null,"collection":["Infectious Disease"],"content":"<h1 id=\"clostridium-difficile-infection-cdi-\">Clostridium Difficile Infection (CDI)</h1>\n<p><strong>TREATMENT</strong></p>\n<table>\n<colgroup>\n<col width=\"50%\" />\n<col width=\"50%\" />\n</colgroup>\n<thead>\n<tr class=\"header\">\n<th><strong>Clinical category</strong></th>\n<th><strong>Therapy</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr class=\"odd\">\n<td>1st episode, <br />\nmild-mod severity</td>\n<td><strong><span class=\"drug\">Metronidazole</span></strong> 500 mg PO TID x 10-14 days</td>\n</tr>\n<tr class=\"even\">\n<td>1st episode, severe</td>\n<td><strong><span class=\"drug\">Vancomycin</span></strong> 125 mg PO QID x 10-14 days</td>\n</tr>\n<tr class=\"odd\">\n<td>1st episode, severe,complicated</td>\n<td><strong><span class=\"drug\">Vancomycin</span></strong> 500 mg QID PO/NG (PR if ileus) PLUS<br />\n\n<p><strong><span class=\"drug\">Metronidazole</span></strong> 500 mg IV q8h</p></td>\n</tr>\n<tr class=\"even\">\n<td>First recurrence</td>\n<td>Same as for 1st episode (b/c minimal resistance<br />\nrate)</td>\n</tr>\n<tr class=\"odd\">\n<td>Second and more recurrences</td>\n<td><strong><span class=\"drug\">Vancomycin</span></strong> PO in tapered or pulsed regimen.<br />\n\n<p><strong>Avoid metronidazole</strong> overuse b/c of neurotoxicity.</p></td>\n</tr>\n</tbody>\n</table>\n\n<h2 id=\"background\">Background</h2>\n<p><strong>Definition of <em>Clostridium difficile</em> infection (CDI)</strong></p>\n<ul>\n<li>Presence of diarrhea (3 unformed stools in ≤24 hours)</li>\n<li>Stool test positive for <em>C. difficile</em> or its toxins, or colonoscopic findings of pseudomembranous colitis</li>\n</ul>\n<p><strong>Epidemiology</strong></p>\n<ul>\n<li>Accounts for 20-30% of all antibiotic-associated diarrhea</li>\n<li>Most common cause of infectious diarrhea in healthcare settings</li>\n</ul>\n<p><strong>Transmission</strong></p>\n<ul>\n<li>Fecal-oral route</li>\n<li>Median time from exposure to C. difficile to diarrhea symptoms = 2-3 days</li>\n</ul>\n<p><strong>Risk factors to develop CDI</strong>\nAge ≥ 65 years\nDuration of hospitalization\nExposure to antibiotics (almost every Abx has been assoc with CDI – not just clindamycin)</p>\n<ul>\n<li>96% have received abx within 14 days before diarrhea onset </li>\n</ul>\n<p>Cancer chemotherapy\nHIV\nGI surgery or manipulation of GI tract (i.e. tube feeding)\n<strong>Clinical presentation</strong></p>\n<ul>\n<li>Diarrhea may have mucous or occult blood</li>\n</ul>\n<p><strong>Recurrence rates</strong></p>\n<ul>\n<li>20% (typically within 4 weeks), despite metronidazole or vanco tx. (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494\">Kelly et al., NEJM, 2008</a>)</li>\n</ul>\n<h2 id=\"complications\">Complications</h2>\n<ul>\n<li>Bowel perforation</li>\n<li>Dehydration</li>\n<li>Electrolyte imbalance </li>\n<li>Hypoalbuminemia</li>\n<li>Hypotension</li>\n<li>Renal failure</li>\n<li>SIRS, sepsis, death</li>\n<li>Toxic megacolon</li>\n</ul>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=20307191\">Cohen SH, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by SHEA and IDSA. Infect Control Hosp Epidemiol. 2010; 31(5):431-55.</a></li>\n<li><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494\">Kelly CP, LaMont JT.Clostridium difficile--more difficult than ever.N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500.</a></li>\n</ul>\n"}}